3-38728741-C-T

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4BP6BS2

The NM_006514.4(SCN10A):​c.2441G>A​(p.Arg814His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000478 in 1,614,142 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R814C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00049 ( 1 hom. )

Consequence

SCN10A
NM_006514.4 missense

Scores

2
4
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:9B:2

Conservation

PhyloP100: -1.70

Publications

12 publications found
Variant links:
Genes affected
SCN10A (HGNC:10582): (sodium voltage-gated channel alpha subunit 10) The protein encoded by this gene is a tetrodotoxin-resistant voltage-gated sodium channel alpha subunit. The properties of the channel formed by the encoded transmembrane protein can be altered by interaction with different beta subunits. This protein may be involved in the onset of pain associated with peripheral neuropathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]
SCN10A Gene-Disease associations (from GenCC):
  • sodium channelopathy-related small fiber neuropathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • episodic pain syndrome, familial, 2
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics
  • Brugada syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Genomics England PanelApp
  • Brugada syndrome 1
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.38756487).
BP6
Variant 3-38728741-C-T is Benign according to our data. Variant chr3-38728741-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 420025.
BS2
High AC in GnomAd4 at 60 AD,Unknown gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN10ANM_006514.4 linkc.2441G>A p.Arg814His missense_variant Exon 16 of 28 ENST00000449082.3 NP_006505.4 Q9Y5Y9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN10AENST00000449082.3 linkc.2441G>A p.Arg814His missense_variant Exon 16 of 28 1 NM_006514.4 ENSP00000390600.2 Q9Y5Y9
SCN10AENST00000643924.1 linkc.2441G>A p.Arg814His missense_variant Exon 15 of 27 ENSP00000495595.1 A0A2R8Y6J6
SCN10AENST00000655275.1 linkc.2468G>A p.Arg823His missense_variant Exon 16 of 28 ENSP00000499510.1 A0A590UJM0

Frequencies

GnomAD3 genomes
AF:
0.000394
AC:
60
AN:
152142
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000588
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.000279
AC:
70
AN:
250764
AF XY:
0.000206
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.000174
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000139
Gnomad NFE exome
AF:
0.000460
Gnomad OTH exome
AF:
0.000652
GnomAD4 exome
AF:
0.000486
AC:
711
AN:
1461882
Hom.:
1
Cov.:
31
AF XY:
0.000448
AC XY:
326
AN XY:
727240
show subpopulations
African (AFR)
AF:
0.0000896
AC:
3
AN:
33480
American (AMR)
AF:
0.000246
AC:
11
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.000104
AC:
9
AN:
86258
European-Finnish (FIN)
AF:
0.000337
AC:
18
AN:
53418
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.000582
AC:
647
AN:
1112006
Other (OTH)
AF:
0.000364
AC:
22
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
44
88
131
175
219
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000394
AC:
60
AN:
152260
Hom.:
0
Cov.:
32
AF XY:
0.000443
AC XY:
33
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.000241
AC:
10
AN:
41550
American (AMR)
AF:
0.000327
AC:
5
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4814
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000588
AC:
40
AN:
68024
Other (OTH)
AF:
0.00237
AC:
5
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000507
Hom.:
0
Bravo
AF:
0.000280
TwinsUK
AF:
0.00162
AC:
6
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000698
AC:
6
ExAC
AF:
0.000313
AC:
38
EpiCase
AF:
0.000709
EpiControl
AF:
0.000237

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:9Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:6
Apr 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 24, 2018
Stanford Center for Inherited Cardiovascular Disease, Stanford University
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:provider interpretation

p.Arg814His (c.2441G>A) in exon 15 of the SCN10A gene (NM_006514.3) Chromosome position: 3:38770232 C / T Found in a male patient with early-onset lone atrial fibrillation. The SCN10A gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with Brugada syndrome (BrS) (PMID: 24998131). Based on the information reviewed below, including this variant’s prevalence in population databases, and how poorly conserved this residue is across evolution, we classify it as a Variant of Uncertain Significance, Probably Benign, concluding that there is not sufficient evidence for its pathogenicity to warrant using it for predictive genetic testing. This variant has been reported in 4 probands: 3 affected with early-onset atrial fibrillation (2 from Savio-Galimberti et al., 2014, PMID: 25053638; and 1 from Jabbari et al., 2015, PMID: 25691686) and 1 with arrhythmogenic right ventricular dysplasia/cardiomyopathy (Te Riele et al., 2016, PMID: 26733327). All reported individuals also carried another change (c.472T>G, p.Tyr158Asp) that was shown to be on the same allele (in cis) in at least three of these cases (Savio-Galimberti et al., 2014, PMID: 25053638; Te Riele et al., 2016, PMID 26733327). Savio-Galimberti et al. (2014) report that in their two families, first degree relatives with the variant(s) did not show atrial fibrillation, possibly due to reduced penetrance. This is a conservative amino acid change, resulting in the replacement of a positively-charged Arginine with a positively-charged Histidine. Arginine at this location is very poorly conserved across ~100 vertebrate species for which we have data. There is no Likely Pathogenic or Pathogenic missense variant currently listed in ClinVar at a nearby residue (+/- 10). Experimental studies in vitro have shown that this missense change generates a peak current that is 4 times larger than that of wild type (Savio-Galimberti et al., 2014; PMID: 25053638). This variant was reported in 85 individuals in the gnomAD database, which includes ~140,000 individuals of European, African, Latino, South Asian, Ashkenazi, and East Asian descent. (MAF = 0.03%.) Specifically, the variant was observed in 63 individuals with non-Finnish European ancestry (for the highest allele frequency: 0.05%), and 7 individuals with Latino ancestry, 5 African ancestry, 4 Finnish ancestry, 3 South Asian ancestry, and 3 “Other”. Our patient’s ancestry is Latino. This variant is present at a higher frequency than would be expected for a pathogenic variant. The phenotype of those individuals is not publicly available. The dataset is comprised of multiple cohorts, some of which were recruited from the general population, others were enriched for common cardiovascular disease. The curators made an effort to exclude individuals with severe pediatric diseases. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 19, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Reported in individuals with atrial fibrillation, arrhythmogenic right ventricular cardiomyopathy (ARVC), AV nodal reentrant tachycardia, or diabetic peripheral neuropathy, many of whom also harbored the p.(Y158D) variant in the SCN10A gene in either cis or unknown configuration (PMID: 25053638, 25691686, 26733327, 28407228, 29396561, 31638414); Published functional studies demonstrated that p.(R814H) generates a peak sodium current approximately four times larger than wild-type SCN10A channels, and when co-expressed with p.(Y158D), the magnitude of the peak current was close to the sum of the average value of the peak currents of each variant expressed individually, such that both variants are reported to contribute to the electrical property of the channel; however, additional studies are needed to validate the functional effect of this variant in vivo (PMID: 25053638); In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 28407228, 25691686, 26733327, 31638414, 29396561, 34426522, 37175987, 25053638) -

-
Clinical Genetics, Academic Medical Center
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 24, 2019
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:1
Jun 19, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: SCN10A c.2441G>A (p.Arg814His) results in a non-conservative amino acid change in the encoded protein sequence. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change. The variant allele was found at a frequency of 0.00048 in 1607170 control chromosomes, predominantly at a frequency of 0.00058 within the Non-Finnish European subpopulation in the gnomAD database, including 1 homozygote. This frequency is not higher than the estimated maximum for a pathogenic variant in SCN10A, allowing no conclusion about variant significance. Of note, this variant is typically reported in the literature as a complex (i.e. on the same allele) with c.472T>G (p.Tyr158Asp), and variant co-occurrence analysis in gnomAD indicates that these two missense variants are on the same haplotype in most individuals. The two missense variants, c.472T>G (p.Tyr158Asp) and c.2441G>A (p.Arg814His), has been observed together in individuals affected with SCN10A-Related Disorders, including arrhythmia and neuropathy, however no segregation evidence was provided to support causality (e.g. Savio-Galimberti_2014, Jabbari_2015, TeRiele_2016, Almomani_2023). At least one publication reported experimental evidence evaluating an impact on protein function, and demonstrated that both missense variants in isolation and together as a complex, affected sodium channel function, resulting in increased currents, and the two missense seemed to result in an additive effect when expressed together (Savio-Galimberti_2014), however, these results do not allow convincing conclusions about the variant effect. The following publications have been ascertained in the context of this evaluation (PMID: 25053638, 25691686, 26733327, 37175987). ClinVar contains an entry for this variant (Variation ID: 420025). Based on the evidence outlined above, the variant was classified as uncertain significance. -

Brugada syndrome 1 Uncertain:1
Oct 14, 2021
MGZ Medical Genetics Center
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Episodic pain syndrome, familial, 2 Uncertain:1
Aug 02, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Brugada syndrome Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Oct 31, 2019
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
0.41
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.59
D;.;D;.
Eigen
Benign
-0.76
Eigen_PC
Benign
-0.93
FATHMM_MKL
Benign
0.029
N
LIST_S2
Benign
0.39
.;T;T;T
M_CAP
Pathogenic
0.67
D
MetaRNN
Benign
0.39
T;T;T;T
MetaSVM
Uncertain
0.58
D
MutationAssessor
Benign
1.2
L;.;L;.
PhyloP100
-1.7
PrimateAI
Benign
0.22
T
PROVEAN
Benign
-1.9
N;.;.;.
REVEL
Pathogenic
0.75
Sift
Uncertain
0.0080
D;.;.;.
Sift4G
Benign
0.076
T;.;.;.
Polyphen
0.93
P;.;P;.
Vest4
0.75
MVP
0.61
MPC
0.074
ClinPred
0.032
T
GERP RS
-1.3
Varity_R
0.064
gMVP
0.39
Mutation Taster
=39/61
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139861061; hg19: chr3-38770232; API